Transcriptomics

Dataset Information

3

EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth


ABSTRACT: Background: The Epithelial Cell Adhesion Molecule (EpCAM) has been shown to be strongly expressed in human breast cancer and cancer stem cells and its overexpression has been supposed to support tumor progression and metastasis. However, effects of EpCAM overexpression on normal breast epithelial cells have never been studied before. Therefore, we analyzed effects of transient adenoviral overexpression of EpCAM on proliferation, migration and differentiation of primary human mammary epithelial cells (HMECs). METHODS: HMECs were transfected by an adenoviral system for transient overexpression of EpCAM. Thereafter, changes in cell proliferation and migration were studied using a real time measurement system. Target gene expression was evaluated by transcriptome analysis in proliferating and polarized HMEC cultures. A Chicken Chorioallantoic Membrane (CAM) xenograft model was used to study effects on in vivo growth of HMECs. RESULTS: EpCAM overexpression in HMECs did not significantly alter gene expression profile of proliferating or growth arrested cells. Proliferating HMECs displayed predominantly glycosylated EpCAM isoforms and were inhibited in cell proliferation and migration by upregulation of p27KIP1 and p53. HMECs with overexpression of EpCAM showed a down regulation of E-cadherin. Moreover, cells were more resistant to TGF-beta1 induced growth arrest and maintained longer capacities to proliferate in vitro. EpCAM overexpressing HMECs xenografts in chicken embryos showed hyperplastic growth, lack of lumen formation and increased infiltrates of the chicken leukocytes. CONCLUSIONS: EpCAM revealed oncogenic features in normal human breast cells by, inducing resistance to TGF-beta1-mediated growth arrest and supporting a cell phenotype with longer proliferative capacities in vitro. EpCAM overexpression resulted in hyperplastic growth in vivo. Thus, we suggest that EpCAM acts as a prosurvival factor counteracting terminal differentiation processes in normal mammary glands. For each gene a representative transcript probe set was selected based on a score that combines average expression and variation of expression across all samples. Transcript probe sets with more than 4 probes were preferred. Differential expression analysis between EPCAM over-expressing and control cells (expressing GFP) was performed using a paired moderated t-test employing functions provided by Bioconductor's limma package. p-values were subsequently adjusted for multiple hypothesis testing using the method from Benjamini and Hochberg for a strong control of the false discovery rate.

ORGANISM(S): Homo sapiens  

SUBMITTER: Agnieszka Martowicz   Gerold Untergasser  Julien Lelong  Guenther Gastl  Gilbert Spizzo  Johannes Rainer 

PROVIDER: E-GEOD-37172 | ArrayExpress | 2013-06-20

SECONDARY ACCESSION(S): GSE37172PRJNA158607

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.

Martowicz Agnieszka A   Rainer Johannes J   Lelong Julien J   Spizzo Gilbert G   Gastl Guenther G   Untergasser Gerold G  

Molecular cancer 20130610


The Epithelial Cell Adhesion Molecule (EpCAM) has been shown to be strongly expressed in human breast cancer and cancer stem cells and its overexpression has been supposed to support tumor progression and metastasis. However, effects of EpCAM overexpression on normal breast epithelial cells have never been studied before. Therefore, we analyzed effects of transient adenoviral overexpression of EpCAM on proliferation, migration and differentiation of primary human mammary epithelial cells (HMECs)  ...[more]

Similar Datasets

2013-06-13 | E-GEOD-39071 | ArrayExpress
2010-11-01 | E-GEOD-23061 | ArrayExpress
| PRJNA169878 | ENA
| PRJNA158607 | ENA
2007-07-12 | GSE8096 | GEO
2008-06-15 | E-GEOD-8096 | ArrayExpress
2014-05-30 | E-GEOD-56801 | ArrayExpress
2010-07-29 | E-GEOD-22580 | ArrayExpress
2015-09-03 | E-GEOD-66182 | ArrayExpress
2015-07-26 | E-GEOD-56718 | ArrayExpress